Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial [PDF]
Aimee Campbell+11 more
openalex +1 more source
Coverage for Opioid Use Disorder Medications in Medicaid Managed Care.
Andrews CM+5 more
europepmc +1 more source
Tailored Therapies in Addiction Medicine: Redefining Opioid Use Disorder Treatment with Precision Medicine. [PDF]
Alag P+5 more
europepmc +1 more source
Drug‐facilitated crime: A review of findings between 2019 and 2023
Abstract Drug‐facilitated crime (DFC) is a criminal act (e.g., assault, robbery, or sexual assault) in which the perpetrator uses drugs to impair the victim's ability to resist, remember, or recognize the crime being committed. Ethanol is commonly implicated in DFC casework, but limited data are published on other substances currently implicated in ...
Meaghan R. Hessler+2 more
wiley +1 more source
Civil Commitment for Opioid and Other Substance Use Disorders: Does It Work? [PDF]
Abhishek Jain+2 more
openalex +1 more source
Opioid Use Disorder Education in the Family Medicine Clerkships: A CERA Study. [PDF]
Sonoda K, Everard KM.
europepmc +1 more source
Abstract Background The increasing prevalence of dementia poses significant challenges for emergency department (ED) care, as persons living with dementia (PLWD) more frequently experience adverse outcomes such as delirium, prolonged stays, and higher mortality rates.
Sangil Lee+20 more
wiley +1 more source
Computerized Clinical Decision Support System for Emergency Department–Initiated Buprenorphine for Opioid Use Disorder: User-Centered Design (Preprint) [PDF]
Jessica M. Ray+9 more
openalex +1 more source
Pharmacokinetics and Pharmacodynamics of Intranasal Diacetylmorphine in Heroin-Assisted Treatment for Severe Opioid Use Disorder. [PDF]
Guessoum A+10 more
europepmc +1 more source
ABSTRACT Objectives Identifying predictors of increased healthcare utilization for hyperglycemia may have important implications for designing interventions to improve patient outcomes and reduce costs. Studies examining predictors of 30‐day recurrent ED hyperglycemia visits have been limited due to their retrospective nature.
Justin W. Yan+8 more
wiley +1 more source